GlaxoSmithKline says annual profits triple to £5.26 bln

February 7, 2012 in Other

British drugmaker GlaxoSmithKline said Tuesday that net profits more than tripled in 2011 compared with the previous year, as large efficiency savings offset falling revenues.

Earnings after tax surged to £5.261 billion (6.34 billion euros, $8.32 billion) in 2011, which compared with £1.634 in the previous year, GSK said in a results statement.

GSK added that it bounced back into the black in the fourth quarter, or three months to December, when net profit hit £1.25 billion. That compared with a net loss of £690 million a year earlier, when GSK took £2.17 billion in legal charges linked to its former diabetes drug Avandia.

The drug was pulled from European shelves in 2010 on fears that it increased the risk of heart attack and strokes.

GSK added Tuesday that revenues fell to £27.387 billion last year, reflecting lower sales of Avandia, anti-viral medicine Valtrex and pandemic flu vaccines.

Chief executive Andrew Witty cautioned about the fragile global economic outlook but predicted the group would increase shareholder returns this year as a result of ongoing efficiency measures.

"As we go into 2012, we are mindful of the potential pressures we face given the current global political and economic environment," Witty said in the release.

"However, we continue to expect to drive further shareholder returns as we seek to grow sales across our broadly based business and improve operational leverage and financial efficiency to deliver strong cash generation.

"We will also continue to invest appropriately in the business to generate sustainable and profitable sales growth," he added.

In early afternoon deals, GSK's share price fell 1.87 percent to 1,393 pence on London's FTSE 100 index of leading companies, which was 0.68 percent lower at 5,852.10 points.

Witty, who took the top job in 2008, has sought to diversify into consumer health care, emerging markets and biotechnology, as the pharmaceuticals industry faces competition from generic drugmakers.

(c) 2012 AFP

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Flesh-eating disease victim gets prosthetic hands

(AP)—A woman who lost both hands, her left leg and right foot after contracting a flesh-eating disease has been fitted with prosthetic hands.

Other created May 18, 2013 | popularity not rated yet | comments 0

Illinois Senate approves medical marijuana bill

(AP)—Medical marijuana use in Illinois is now in Gov. Pat Quinn's hands after the state Senate approved legislation.

Other created May 17, 2013 | popularity 5 / 5 (1) | comments 0

Nigerian court jails two over killer teething drug

A Nigerian court on Friday sentenced two officials from a pharmaceutical company to seven years in prison over the sale of an adulterated teething drug which killed 84 babies in 2008.

Other created May 17, 2013 | popularity not rated yet | comments 0

Many patients would switch doc to cut health care costs

(HealthDay)—Many Americans feel that keeping out-of-pocket health care costs is more important than staying with the same primary care physician.

Other created May 17, 2013 | popularity not rated yet | comments 0

Cultural attitudes impede organ donations in China

(AP)—China is phasing out its reliance on executed prisoners for donated organs, but an architect of the country's transplant system said Friday that ingrained cultural attitudes are impeding the rise of ...

Other created May 17, 2013 | popularity not rated yet | comments 0


Ketamine shows significant therapeutic benefit in people with treatment-resistant depression

Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...

Consuming coffee linked to lower risk of detrimental liver disease, study finds

Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...

Research examines new methods for managing digestive health

Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.

New smartphone application improves colonoscopy preparation

The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...

New research identifies practice changes to improve value and quality of GI procedures

There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week (DDW).

New research identifies risks, interventions for children's GI health

An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).